Drug‐eluting versus bare‐metal stents for saphenous vein graft lesions

A best evidence topic was written addressing the question ‘in patients with saphenous vein graft lesions requiring percutaneous coronary intervention, do long‐term clinical outcomes differ between drug‐eluting and bare‐metal stents?’ Altogether 1466 papers were found, of which seven represented the...

Full description

Saved in:
Bibliographic Details
Published in:Internal medicine journal 2019-12, Vol.49 (12), p.1534-1537
Main Authors: Conte, Sean M., Florisson, Daniel S., De Bono, Joshua A., Vale, Peter R.
Format: Article
Language:English
Subjects:
Angioplasty, Balloon, Coronary
bare‐metal stent
Coronary Artery Bypass
coronary artery disease
Drug-Eluting Stents
drug‐eluting stent
Graft Occlusion, Vascular - surgery
Humans
Implants
interventional cardiology
ischaemic heart disease
Metals
Paclitaxel
percutaneous coronary intervention
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Saphenous Vein - pathology
Saphenous Vein - surgery
Saphenous Vein - transplantation
Stents
Varicose veins
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A best evidence topic was written addressing the question ‘in patients with saphenous vein graft lesions requiring percutaneous coronary intervention, do long‐term clinical outcomes differ between drug‐eluting and bare‐metal stents?’ Altogether 1466 papers were found, of which seven represented the best evidence. Although one major recent randomised trial was neutral, the weight of earlier evidence supports drug‐eluting stents as standard of care. Bare‐metal stents may represent a reasonable, efficacious, and less expensive alternative to drug‐eluting stents in well selected patient groups.
ISSN:1444-0903
1445-5994
DOI:10.1111/imj.14659